Sarepta's Duchenne gene therapy clears study hurdle, although questions linger

Retrieved on: 2021-05-18 16:18:45

Tags for this article:

Click the tags to see associated articles and topics

Sarepta's Duchenne gene therapy clears study hurdle, although questions linger. View article details on hiswai:

Excerpt

Recommended Reading: BioPharma Dive Sarepta gene therapy misses goal in key muscular dystrophy study offsite link. Follow Ben Fidler on Twitter.

Article found on: www.biopharmadive.com